Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Perlmutter

Showing results (441-450 of 570) with videos related to

Pageof 57
Sort By:
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 20, 2019
Psychometric properties and responsiveness of Neuro-QoL Cognitive Function in persons with Huntington disease (HD)Noelle E Carlozzi, Nicholas R Boileau, Jane S Paulsen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 15, 2019
How different aspects of motor dysfunction influence day-to-day function in huntington's diseaseNoelle E Carlozzi, Stephen G Schilling, Nicholas R Boileau, et al.
Journal of Neurology|April 25, 2018
Agreement between clinician-rated versus patient-reported outcomes in Huntington diseaseNoelle E Carlozzi, Nicholas R Boileau, Joel S Perlmutter, et al.
Journal of Medicinal Chemistry|June 6, 2025
Design and Synthesis of Novel PET Radiotracers for Imaging Sphingosine-1-Phosphate Receptor 5 (S1PR5) in the BrainJiawen Lang, Wenjuan Zhou, Tianyu Huang, et al.
Journal of Neurochemistry|April 24, 2026
Kinetic Modeling of a Novel Putative Sphingosine-1-Phosphate Receptor 1 (S1PR1) Radiotracer [<sup>18</sup>F]TZ82112 in Nonhuman PrimatesYing-Hwey Nai, Lin Qiu, Hao Jiang, et al.
ACS Chemical Neuroscience|April 18, 2024
Metabolite Study and Structural Authentication for the First-in-Human Use Sphingosine-1-phosphate Receptor 1 RadiotracerLin Qiu, Hao Jiang, Kevin Cho, et al.
Journal of Neurology|June 14, 2019
End-of-life measures in Huntington disease: HDQLIFE Meaning and Purpose, Concern with Death and Dying, and End of Life PlanningNoelle E Carlozzi, Nicholas R Boileau, Jane S Paulsen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 19, 2020
Resting-State Functional Connectivity Predicts STN DBS Clinical ResponseJohn R Younce, Meghan C Campbell, Tamara Hershey, et al.
Cells|August 13, 2025
Pilot Study of [<sup>11</sup>C]HY-2-15: A Mixed Alpha-Synuclein and Tau PET RadiotracerChia-Ju Hsieh, Dinahlee Saturnino Guarino, Anthony J Young, et al.
Neurology|April 14, 2022
Proteinopathy and Longitudinal Cognitive Decline in Parkinson DiseasePeter S Myers, John L O'Donnell, Joshua J Jackson, et al.
Pageof 57

Showing results (441-450 of 570) with videos related to

Sort By:
Pageof 57
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 20, 2019
Psychometric properties and responsiveness of Neuro-QoL Cognitive Function in persons with Huntington disease (HD)Noelle E Carlozzi, Nicholas R Boileau, Jane S Paulsen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 15, 2019
How different aspects of motor dysfunction influence day-to-day function in huntington's diseaseNoelle E Carlozzi, Stephen G Schilling, Nicholas R Boileau, et al.
Journal of Neurology|April 25, 2018
Agreement between clinician-rated versus patient-reported outcomes in Huntington diseaseNoelle E Carlozzi, Nicholas R Boileau, Joel S Perlmutter, et al.
Journal of Medicinal Chemistry|June 6, 2025
Design and Synthesis of Novel PET Radiotracers for Imaging Sphingosine-1-Phosphate Receptor 5 (S1PR5) in the BrainJiawen Lang, Wenjuan Zhou, Tianyu Huang, et al.
Journal of Neurochemistry|April 24, 2026
Kinetic Modeling of a Novel Putative Sphingosine-1-Phosphate Receptor 1 (S1PR1) Radiotracer [<sup>18</sup>F]TZ82112 in Nonhuman PrimatesYing-Hwey Nai, Lin Qiu, Hao Jiang, et al.
ACS Chemical Neuroscience|April 18, 2024
Metabolite Study and Structural Authentication for the First-in-Human Use Sphingosine-1-phosphate Receptor 1 RadiotracerLin Qiu, Hao Jiang, Kevin Cho, et al.
Journal of Neurology|June 14, 2019
End-of-life measures in Huntington disease: HDQLIFE Meaning and Purpose, Concern with Death and Dying, and End of Life PlanningNoelle E Carlozzi, Nicholas R Boileau, Jane S Paulsen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 19, 2020
Resting-State Functional Connectivity Predicts STN DBS Clinical ResponseJohn R Younce, Meghan C Campbell, Tamara Hershey, et al.
Cells|August 13, 2025
Pilot Study of [<sup>11</sup>C]HY-2-15: A Mixed Alpha-Synuclein and Tau PET RadiotracerChia-Ju Hsieh, Dinahlee Saturnino Guarino, Anthony J Young, et al.
Neurology|April 14, 2022
Proteinopathy and Longitudinal Cognitive Decline in Parkinson DiseasePeter S Myers, John L O'Donnell, Joshua J Jackson, et al.
Pageof 57